The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Obesity and diabetes have been two of the greatest public health challenges for decades. Many different diets and fads have promised the public ...

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

Data submitted to the UK drugs regulator show a total of 82 deaths related to glucagon-like peptide-1 receptor agonists, the class of drugs used for weight loss and type 2 diabetes. Data from the ...

In response to the growing interest in glucagon-like peptide-1 (GLP-1) weight-loss medications and the cost challenges employers face to offer coverage, Liviniti, a national leader in ...

People taking weight loss medications like Ozempic may want to modify their exercise routine in order to reap the maximum benefits of these drugs while staying healthy overall. Here's how to safely ...

The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...

PMGC Holdings Inc. (the “Company,” “PMGC,” “us,” or “we”) (Nasdaq:ELAB), a diversified holding company, today announced an ...

A target trial emulation study compared risk for depression among older adults with type 2 diabetes initiating treatment with ...

PMGC Holdings Inc. (the "Company," "PMGC," "us," or "we") (Nasdaq:ELAB), a diversified holding company, today announced an update on its capital ...

There used to be no specific treatments for heart failure with preserved ejection fraction, but recent clinical trials show ...